Industry Insight
Company News
Industry Insights

Home > News > Industry Insight > Wecare Probiotics' BLa80 Officially Included in China's Infant Probiotic Strain Whitelist, Reinforcing Commitment to Safety

Wecare Probiotics' BLa80 Officially Included in China's Infant Probiotic Strain Whitelist, Reinforcing Commitment to Safety

July 03 2025

Bifidobacterium lactis strain, BLa80

SHANGHAI, CHINA – July 2, 2025 – Wecare Probiotics, a leading innovator in the probiotic industry, today proudly announced that its advanced Bifidobacterium lactis strain, BLa80, has been officially included in China's national whitelist of probiotic strains approved for use in infant and young children's food. This significant regulatory recognition highlights BLa80's exceptional safety profile and suitability for critical applications in early life nutrition.

 

China's Infant Probiotic Strain Whitelist

China's regulatory landscape for ingredients used in infant and young children's food products is globally recognized for its stringent requirements and thorough review processes. BLa80's successful inclusion on this national whitelist is a direct testament to the comprehensive safety data, robust scientific evidence, and rigorous quality controls meticulously applied during its development and production.

"The official inclusion of BLa80 in China's highly selective infant probiotic strain whitelist is a pivotal achievement for Wecare Probiotics," stated Frank Fang, founder and CSO of Wecare. "This milestone profoundly reaffirms our unwavering commitment to the highest safety standards and exceptional quality. At Wecare Probiotics, food safety is not just a priority; it is our core mission, embodying our philosophy of 'QUALITY PROBIOTICS, QUALITY LIFE.' Ensuring the safety and well-being of infants and young children is paramount, and this recognition provides invaluable assurance to manufacturers and parents alike."

BLa80 is a clinically researched strain. Its approval for use in this sensitive market segment underscores Wecare Probiotics' capability to meet and exceed stringent global safety regulations. This inclusion is expected to open new avenues for partners looking to develop premium, safe, and effective probiotic products specifically tailored for infant and young children's nutritional needs within the Chinese market and potentially inspire similar confidence internationally.

About Wecare Probiotics:

Based on microbiome, Wecare Probiotics specialize in microbial resource mining, research of probiotic strains and beneficial microorganisms in relation to human health, agriculture, animal husbandry and ecological environments, as well as high-bioavailability strain industrialization and large-scale intelligent biomanufacturing. As a leading technological innovator, Wecare focuses on probiotic strain applications for foods, dietary supplements, fermented foods, and related area, delivering high-quality strains and comprehensive solutions.

No.999,Guangming Rd., Wujiang Economic and Technological Development Zone, Suzhou City, Jiangsu Province, China
Online Message
Leave a Message